<DOC>
	<DOCNO>NCT00625001</DOCNO>
	<brief_summary>Turner Syndrome ( TS ) associate osteopenia osteoporosis . Reduced bone mineral density ( BMD ) increase risk fracture present many young middle-aged woman TS . The objective therefore describe longitudinal change BMD TS . The study observational follow-up study . Examinations baseline , 5 10 year . Bone mineral density measure dual energy x-ray absorptiometry ( DEXA ) bone turnover bone marker . Main Outcome Measures : Bone mineral density ( BMD ; grams/ square centimetre ) measure lumbar spine , hip non-dominant forearm .</brief_summary>
	<brief_title>Long Term Follow-up Bone Mineral Density Hormone Treated Turner Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Turner syndrome verified karyotyping untreated hypothyroidism hyperthyroidism present past malignant diseases clinical liver disease treatment drug know interfere bone metabolism ( e.g . glucocorticoid )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Turner Syndrome</keyword>
	<keyword>bone mineral density</keyword>
	<keyword>estrogen replacement therapy</keyword>
	<keyword>dual energy x-ray absorptiometry</keyword>
</DOC>